SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-037528
Filing Date
2019-08-05
Accepted
2019-08-05 08:29:07
Documents
7
Period of Report
2019-09-10
Effectiveness Date
2019-08-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv526111_def14a.htm DEF 14A 478659
2 GRAPHIC image_002.jpg GRAPHIC 111386
3 GRAPHIC image_003.jpg GRAPHIC 84833
4 GRAPHIC tv526111_img01.jpg GRAPHIC 4885
5 GRAPHIC tv526111_img02.jpg GRAPHIC 4807
6 GRAPHIC stergiou.jpg GRAPHIC 2101
7 GRAPHIC wood.jpg GRAPHIC 2657
  Complete submission text file 0001144204-19-037528.txt   770896
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 19997632
SIC: 2834 Pharmaceutical Preparations